Extendicare Inc. (TSX:EXE)
Canada · Delayed Price · Currency is CAD 32.74
+0.47 (1.46%)
Aug 14, 2026, 4:00 PM EST
Extendicare Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,979 | 1,660 | 1,466 | 1,305 | 1,222 | 1,167 | |
Revenue Growth | 31.14% | 13.25% | 12.36% | 6.83% | 4.68% | 5.75% |
Cost of Revenue | 1,692 | 1,424 | 1,265 | 1,154 | 1,003 | 1,051 |
Gross Profit | 286.85 | 236.84 | 201.49 | 151.02 | 218.83 | 115.61 |
Selling, General & Admin | 65.44 | 61.22 | 56.94 | 55.84 | 50.78 | 52.43 |
Operating Expenses | 111.82 | 98.17 | 90.28 | 88.06 | 82.33 | 83.26 |
Operating Income | 175.02 | 138.67 | 111.21 | 62.96 | 136.5 | 32.35 |
Interest Expense | -23.8 | -18.72 | -20.15 | -20.63 | -20.61 | -21.16 |
Interest & Investment Income | 6.72 | 5.73 | 7.04 | 6.19 | 5.02 | 1.87 |
Earnings From Equity Investments | 2.52 | 1.85 | 1.93 | 0.02 | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.25 |
Other Non Operating Income (Expenses) | -7.2 | -1.37 | -2.63 | -1.06 | -0.84 | -1.21 |
EBT Excluding Unusual Items | 153.27 | 126.17 | 97.41 | 47.49 | 120.06 | 11.59 |
Merger & Restructuring Charges | -15.07 | -8.59 | -6.04 | -11.81 | -9.01 | - |
Impairment of Goodwill | - | - | - | - | - | -5.83 |
Gain (Loss) on Sale of Investments | 8.93 | 12.52 | 2.92 | 9.12 | - | - |
Gain (Loss) on Sale of Assets | 10.02 | - | 8.23 | - | - | - |
Asset Writedown | - | - | -2.66 | - | -4.94 | -9.14 |
Other Unusual Items | - | - | - | - | -110.6 | 17.36 |
Pretax Income | 157.15 | 130.1 | 99.86 | 44.8 | -4.5 | 13.99 |
Income Tax Expense | 35.87 | 33.45 | 24.65 | 10.82 | 0.02 | 6.48 |
Earnings From Continuing Operations | 121.28 | 96.66 | 75.21 | 33.98 | -4.51 | 7.5 |
Earnings From Discontinued Operations | - | - | - | - | 74.07 | 4 |
Net Income | 121.28 | 96.66 | 75.21 | 33.98 | 69.55 | 11.5 |
Net Income to Common | 121.28 | 96.66 | 75.21 | 33.98 | 69.55 | 11.5 |
Net Income Growth | 45.80% | 28.52% | 121.32% | -51.14% | 504.61% | -78.77% |
Shares Outstanding (Basic) | 91 | 85 | 84 | 85 | 89 | 90 |
Shares Outstanding (Diluted) | 92 | 87 | 95 | 85 | 89 | 90 |
Shares Change | 2.00% | -8.93% | 12.21% | -4.52% | -1.09% | 0.20% |
EPS (Basic) | 1.33 | 1.13 | 0.89 | 0.40 | 0.78 | 0.13 |
EPS (Diluted) | 1.31 | 1.11 | 0.86 | 0.40 | 0.78 | 0.12 |
EPS Growth | 37.40% | 29.64% | 114.71% | -48.83% | 527.91% | -79.28% |
Free Cash Flow | 98.28 | 103.69 | 101.69 | -106.13 | -2.76 | -6.1 |
Free Cash Flow Per Share | 1.06 | 1.19 | 1.07 | -1.25 | -0.03 | -0.07 |
Dividend Per Share | 0.512 | 0.500 | 0.480 | 0.480 | 0.480 | 0.480 |
Dividend Growth | 5.00% | 4.17% | 0% | 0% | 0% | 0% |
Gross Margin | 14.50% | 14.26% | 13.74% | 11.57% | 17.91% | 9.91% |
Operating Margin | 8.85% | 8.35% | 7.58% | 4.83% | 11.17% | 2.77% |
Profit Margin | 6.13% | 5.82% | 5.13% | 2.60% | 5.69% | 0.99% |
Free Cash Flow Margin | 4.97% | 6.25% | 6.94% | -8.13% | -0.23% | -0.52% |
EBITDA | 207.46 | 167.41 | 134.44 | 83.22 | 158.41 | 68.17 |
EBITDA Margin | 10.48% | 10.08% | 9.17% | 6.38% | 12.97% | 5.84% |
D&A For EBITDA | 32.44 | 28.74 | 23.22 | 20.26 | 21.91 | 35.83 |
EBIT | 175.02 | 138.67 | 111.21 | 62.96 | 136.5 | 32.35 |
EBIT Margin | 8.85% | 8.35% | 7.58% | 4.83% | 11.17% | 2.77% |
Effective Tax Rate | 22.82% | 25.71% | 24.69% | 24.15% | - | 46.34% |